Current and emerging pharmacological treatments for visceral leishmaniasis
Microbial Pathogenesis · 2026
DOI: 10.1016/j.micpath.2026.108318 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Sijia Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Leishmaniasis, Visceral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 116 Literaturangaben. Gefördert von: First Affiliated Hospital of Xi'an Jiaotong University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
- School of Basic Medical Sciences, Tsinghua University, Beijing, 100084, China. Electronic address: lmzhang1994@gmail.com.
- Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China. Electronic address: wxq1493722680@xjtufh.edu.cn.
Förderung
- First Affiliated Hospital of Xi'an Jiaotong University
Zitieren
APA
Li, S., Zhang, L., & Wang, X. (2026). Current and emerging pharmacological treatments for visceral leishmaniasis. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2026.108318
Vancouver
Li S, Zhang L, Wang X. Current and emerging pharmacological treatments for visceral leishmaniasis. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2026.108318
BibTeX
@article{Li2026,
author = {Li, Sijia and Zhang, Liming and Wang, Xiaoqin},
title = {Current and emerging pharmacological treatments for visceral leishmaniasis},
journal = {Microbial Pathogenesis},
year = {2026},
doi = {10.1016/j.micpath.2026.108318}
}
EUVIMED